Articles by Rebecca Killion, MA
Understanding and Improving Value Frameworks With Real-World Patient Outcomes
ByAnupam B. Jena, MD, PhD,Jacquelyn W. Chou, MPP, MPL,Lara Yoon, MPH,Wade M. Aubry, MD,Jan Berger, MD, MJ,Wayne Burton, MD,A. Mark Fendrick, MD,Donna M. Fick, RN, PhD,David Franklin, BA,Rebecca Killion, MA,Darius N. Lakdawalla, PhD,Peter J. Neumann, ScD,Kavita Patel, MD, MSHS,John Yee, MD, MPH,Brian Sakurada, PharmD,Kristina Yu-Isenberg, PhD, MPH, RPh New value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Improving Patient-Centered Care in Diabetes With Comparative Effectiveness Research
ByDouglas K. Owens, MD,Wade Aubry, MD,Roy Beck, MD,Joshua Benner, MD,Jan E. Berger, PharmD,Michael E. Chernew, PhD,Felicia Forma, BSc,Dana P. Goldman, PhD,William H. Herman, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Anne L Peters, MD Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Comparative Effectiveness Research and Formulary Placement: The Case of Diabetes
ByMichael E. Chernew, PhD,Rick McKellar, BS,Wade Aubry, MD,Roy Beck, MD, PhD,Joshua Benner, PharmD, ScD,Jan E. Berger, MD, MJ,A. Mark Fendrick, MD,Felicia Forma, BSc,Dana Goldman, PhD,Anne Peters, MD,Rebecca Killion, MA,Darius Lakdawalla, PhD,Douglas K. Owens, MD,Joe Stahl, MA Formularies of the future should use evidence-produced CER to better target, not limit, diabetes care.